By Sachman Kochar , 18 January 2026

Gold and silver prices remained in focus as investors assessed a mix of global economic signals, currency movements, and inflation expectations. Precious metals continued to reflect cautious optimism, supported by demand for safe-haven assets amid uncertainty over interest rate trajectories and geopolitical developments. While short-term volatility persisted, underlying fundamentals pointed to sustained investor interest, particularly from hedgers and long-term allocators.

By Sachman Kochar , 17 January 2026

India’s unemployment rate increased to 4.8% in December, signaling a modest but notable rise in joblessness compared with previous months. Analysts attribute the uptick to seasonal employment fluctuations, slowing hiring in certain sectors, and persistent structural challenges in labor markets. While urban job markets remain relatively stable, rural employment faced headwinds due to weaker agricultural activity and delayed public works projects. Economists are closely monitoring the data for its implications on consumption, wage growth, and overall economic recovery.

By Binnypriya Singh , 17 January 2026

InterGlobe Aviation Ltd., the operator of IndiGo, is scheduled to announce its third-quarter financial results on Jan. 22, with market participants closely watching trends in passenger demand, operating margins, and cost pressures. The airline is expected to benefit from strong domestic travel demand and disciplined capacity deployment, even as challenges such as fuel costs, currency movement, and competitive pricing remain in focus.

By Sachman Kochar , 17 January 2026

The Indian rupee weakened sharply to Rs. 90.44 against the US dollar, reflecting mounting pressure from global economic uncertainty and sustained dollar strength. The decline underscores challenges facing emerging market currencies as higher US interest rates, volatile crude oil prices, and cautious investor sentiment weigh on capital flows. Despite intervention measures and supportive domestic fundamentals, the rupee struggled to hold ground amid risk-off trade globally.

By Binnypriya Singh , 17 January 2026

Infosys shares moved sharply higher after the IT major reported earnings that exceeded market expectations and raised its guidance for FY26. The upgraded outlook reflects improving demand conditions, stronger deal wins, and better execution across key client segments. Management highlighted early signs of recovery in discretionary spending, particularly in digital transformation and cloud-led services. While challenges persist in certain geographies, the company’s confident tone reassured investors about revenue visibility and margin stability.

By Gurjot Singh , 17 January 2026

Federal Bank reported a resilient financial performance in the third quarter, posting a 9% year-on-year rise in net profit to Rs. 1,041 crore. The results underscore the bank’s ability to navigate a complex operating environment marked by fluctuating interest rates and cautious credit demand. Growth was supported by stable core income, disciplined cost management, and improving asset quality. The quarter reflected a balanced strategy focused on sustainable lending, prudent risk control, and incremental expansion across key segments.

By Binnypriya Singh , 17 January 2026

Sony India has initiated a strategic restructuring exercise that includes changes in senior leadership and a reduction in its workforce, signaling a recalibration of priorities amid shifting market dynamics. The move reflects broader efforts by global consumer electronics companies to streamline operations, manage costs, and sharpen focus on high-growth segments. While the company continues to reaffirm its long-term commitment to the Indian market, the internal reorganization underscores pressures from slowing demand, intense competition, and evolving consumer preferences.

By Eknath Deshpande , 17 January 2026

Sun Pharmaceutical Industries has expanded its presence in the global oncology space with the launch of a new skin cancer treatment, Unloxcyt, in the United States. The introduction marks a strategic milestone for India’s largest drugmaker as it deepens its focus on specialty and complex therapies in regulated markets. The drug targets a specific segment of skin cancer patients and reflects Sun Pharma’s sustained investment in research, development, and regulatory approvals. Industry experts view the launch as a calculated move to strengthen the company’s U.S.

By Sachman Kochar , 17 January 2026

Leela Hotels posted a sharp improvement in its financial performance for the third quarter, reporting a more than twofold rise in net profit to Rs. 147.88 crore. The results highlight the sustained recovery in India’s premium hospitality sector, driven by strong domestic travel, higher room rates, and improved operating efficiency. Steady demand from business travelers, weddings, and luxury tourism supported revenue growth, while disciplined cost management amplified margins.

By Binnypriya Singh , 16 January 2026

India’s job market showed renewed strength in December, with hiring activity rising 15 percent compared with the previous year, signaling improving business confidence across multiple sectors. The uptick reflects steady demand in technology, manufacturing, financial services, and emerging digital roles, supported by resilient domestic consumption and selective corporate expansion. Recruiters note that companies are focusing on skill-based hiring rather than large-scale workforce additions, emphasizing productivity and efficiency.